In O
March O
2012 O
, O
an O
unknown O
time O
after O
receiving O
FLULAVAL B-procedure
, O
the O
patient O
experienced O
cataplexy B-nervous_AE
( O
serious O
criteria O
hospitalization O
and O
GSK O
medically O
significant O
) O
, O
unable B-nervous_AE
to I-nervous_AE
walk I-nervous_AE
( O
serious O
criteria O
hospitalization O
and O
GSK O
medically O
significant O
) O
, O
Guillain B-nervous_AE
Barre I-nervous_AE
syndrome I-nervous_AE
( O
serious O
criteria O
hospitalization O
and O
GSK O
medically O
significant O
) O
and O
viral B-other_AE
infection I-other_AE
( O
serious O
criteria O
hospitalization O
) O
. O
